about
Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk.Can we accurately report PTEN status in advanced colorectal cancer?Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerPharmacological blockade of aquaporin-1 water channel by AqB013 restricts migration and invasiveness of colon cancer cells and prevents endothelial tube formation in vitro.Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab.High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients treated with cetuximab.Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cells.High-affinity monoclonal antibodies against P-glycoprotein.Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancerMeasurement of an analog of insulin-like growth factor-I in blood plasma using a novel enzyme-linked immunosorbent assay
P50
Q34549156-FA83487F-E628-4293-BF95-F9A2280E2E89Q35101357-59CD266C-D433-4821-A4CF-6EC035BD2043Q35198335-1731CF49-27E7-4000-81AD-CF9C077ABFE9Q35935029-CC5B6669-61BC-4BC1-B570-8C8E18E89211Q36977406-7EE3B4C0-1AD8-4B54-B11B-755E7A3C2F68Q38724794-249B0C13-0C1F-44F6-A51C-0D2C1CE8016EQ38943122-798A2C74-EFE4-44D6-AF46-6A50F5E0B89CQ46839405-638BEAA9-2D2D-480C-B769-A22247E01853Q54584514-4D9E2027-7F41-4D3C-85FF-1C96E75D8A5EQ61867780-82893DAF-2333-4A8B-AA5A-2F12AD6B7A3CQ74531975-23ED8333-84C2-4673-98E3-E99B3FE2C38A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
J Wrin
@ast
J Wrin
@en
J Wrin
@es
J Wrin
@nl
type
label
J Wrin
@ast
J Wrin
@en
J Wrin
@es
J Wrin
@nl
prefLabel
J Wrin
@ast
J Wrin
@en
J Wrin
@es
J Wrin
@nl
P106
P31
P496
0000-0003-3584-7343